KENYA SIGNS GLOBAL FUND GRANT AMOUNTING TO USD 407,989,068 (KSH 59.7 BILLION) TO SUPPORT HIV, TB & MALARIA INTERVENTIONS

Nairobi, 24th June 2024 — Kenya has today signed six Global Fund grants amounting to USD 407,989,068 (KSH 59.7 BILLION to support HIV, TB & Malaria intervention and strengthen health and community systems during the implementation period of three years (July 2024 to June 2027). The total amount for each component includes;

HIV Grant USD 232,580,654
Malaria Grant USD 72,934,665
TB Grant USD 67,785,529
Health systems strengthening USD 34,688,220

The Global Fund is a partnership between Governments, civil society, the private sector and people affected by diseases designed to accelerate the end of AIDS, Tuberculosis and Malaria epidemics globally. The Kenya Coordinating Mechanism includes members of government, civil society, private sector and people living with the disease to present funding proposals to the Global Fund and to monitor program implementation.

Since 2003, the Global Fund support has helped the country achieve tremendous outcomes.

In HIV, the Global Fund has supported the procurement of commodities e.g. Antiretrovirals (ARVs), HIV test kits, Condoms and Laboratory reagents. They have also supported programmatic interventions at both at health facilities and community level.

There has been a remarkable decline in new HIV infections, HIV-related mortality, and mother-to- child transmission by 78%, 68%, and 65% respectively. These significant reductions are due to increased access to HIV testing, treatment, and prevention services at community and facility level. Currently, nearly 1.4m Persons living with HIV are receiving lifesaving treatment at various facilities across the country. This progress is attributed to the decentralization of HIV services and collaboration between Government, development Partners, non-state actors, stakeholders, counties and communities.

With respect to the TB programme, we have recorded a treatment success rate of 86%. The average positivity rate among TB presumptive cases declined from 7.35% in 2021 to 5.6% in March 2024 while the absolute number tested more than doubled from 245,902 in 2021 to 502,970 in March 2024. The Global Fund has partnered with the Government of Kenya and provided support for the establishment of 1,933 community health units, training of 18,500 community health promotors CHPS and 3,700 Community Health Extension Workers (CHEWs). Similarly, the Malaria programme has contributed to the overall reduction of malaria burden in Kenya, with the national level prevalence declining from 8.2% in 2015 to 6% in 2023.

In partnership with the Government of Kenya, the Global Fund invested US$ 9.5m in the construction, equipping and digitization of KEMSA National Supply Chain Centre. This investment will enhance supply chain, support service delivery at Primary Health Care and with adequate storage, and strengthen responses to pandemics and emergencies resulting from climate change.

This investment is a good example of multi partner investment over a period of time. Building resilient systems takes a lot of time and resilience. KEMSA, Development Partners and other stakeholders should be congratulated for achieving this milestone.

The new Global Fund grants will support;

Provision of quality care and prevention services for all people with TB, leprosy and lung diseases.
Contribute to attainment of Universal Health Coverage through comprehensive HIV prevention, treatment and care.
Reduce malaria incidence and deaths by at lea 75 percent by 2027.
Strengthening of Health systems at facility and community level.
Procurement of TB, Malaria and HIV commodities including medicines, laboratory supplies and test kits.
Primary health care activities at the community level in line with universal health care agenda.
Social support and Social Health Insurance Fund (SHIF) premiums for TB/HIV/Malaria needy patients to access full SHIF benefit package.

To get in touch, please contact us.

ENDS